Paratek Pharmaceuticals Inc (USD)
PRTK
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range3.09 | 3.29
52-Wk Range2.66 | 7.39
Last Close3.27
Mkt Cap (m)108.85
Dividend yield-
ISINUS6993743029
Volume535,227
Exchange VenueNAS

Company Profile

Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics based upon tetracycline chemistry.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales4.31
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -607.87
Net Margin %-656.40
Return on Equity-172.78
Debt/Equity4.81

Legal Documents

Prospectus
en 03/07/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)241317
Operating Income (m)-24-7-71-110-84-104
Net Income (m)-27-18-71-112-89-112
Basic EPS-17.52-7.82-4.29-5.51-3.32-3.57
Avg. Diluted Shares Outstanding (m)2317202732
Balance Sheet
USD201320142015201620172018
Current Assets (m)74101142132160255
Non Current Assets (m)944345
Total Assets (m)74110146136164300
Current Liabilities (m)2421201718
Total Liabilities (m)------
Total Equity (m)7295101728248
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-15-19-55-94-79-81
Capital Expenditure (m)---1-1-1
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
3.27
Last Price